Home » Topics » Coronavirus, BioWorld

Coronavirus, BioWorld
RSS

Collaborations Between Biotech And Pharmaceutical Companies: Aug. 19-Oct. 19, 2005

Oct. 24, 2005

New SARS Target Discoveries;Fresh Therapeutic Approaches

Sep. 19, 2005

By Anette Breindl

Analysts: Interest In Antisense Waning, But Science Not Dead

Sep. 16, 2005

Other News To Note

Sep. 13, 2005

Other News To Note

July 20, 2005

Found Coronavirus Might Have Ties To Pediatric Heart Disease

Feb. 11, 2005

By Anette Breindl

Driving A Spike Through Heart Of SARS Proving Challenging

Jan. 18, 2005

By Anette Breindl

Other News To Note

Dec. 7, 2004

Other News To Note

Oct. 12, 2004

From Cellular Trash To Receptor Families, Awards Season Arrives

Oct. 7, 2004

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.